Aqueous ginseng extract has a preventive role in RANKL-induced osteoclast differentiation and estrogen deficiency-induced osteoporosis

Journal of Functional Foods

Volumn 13, Issue , 2015, Pages 192-203

  Lee, Hwa Young ^a   Park, Soo Hyun ^b   Chae, Soo Wan ^a,b   Soung, Nak Kyun ^c,d   Oh, Mi Jin ^c   Kim, Jin Sung ^e   Kim, Young Ock ^e   Chae, Han Jung ^a  

^a Chonbuk National University   (South Korea)

^b Chonbuk National University Medical School and Hospital   (South Korea)

^c Korean Research Institute of Biosciences and Biotechnology   (South Korea)

^d Chungnam National University   (South Korea)

^e Rural Development Administration   (South Korea)

Author keywords

Bone mineral density; Ginseng; Osteoclast differentiation; Ovariectomy

Indexed keywords

PANAX GINSENG; RATTUS;

EID: 84922569579     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.12.039     Document Type: Article

References (34)

1. Bahlous A., Kalai E., Hadj Salah M., Bouzid K., Zerelli L. Biochemical markers of bone remodeling: Recent data of their applications in managing postmenopausal osteoporosis. La tunisie Medicale 2006, 84(11):751-757.
2. Brouwers J.E., Lambers F.M., Gasser J.A., van Rietbergen B., Huiskes R. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. Calcified Tissue International 2008, 82(3):202-211.
3. Cheng B., Li J., Du J., Lv X., Weng L., Ling C. Ginsenoside Rb1 inhibits osteoclastogenesis by modulating NF-kappaB and MAPKs pathways. Food and Chemical Toxicology 2012, 50(5):1610-1615.
4. Cho H.M., Kang Y.H., Yoo H., Yoon S.Y., Kang S.W., Chang E.J., Song Y. Panax red ginseng extract regulates energy expenditures by modulating PKA dependent lipid mobilization in adipose tissue. Biochemical and Biophysical Research Communications 2014, 447(4):644-648.
5. Choi Y.S., Kang E.H., Lee E.Y., Gong H.S., Kang H.S., Shin K., Lee E.B., Song Y.W., Lee Y.J. Joint-protective effects of compound K, a major ginsenoside metabolite, in rheumatoid arthritis: In vitro evidence. Rheumatology International 2013, 33(8):1981-1990.
6. Dang Z.C., van Bezooijen R.L., Karperien M., Papapoulos S.E., Lowik C.W. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. Journal of Bone and Mineral Research 2002, 17(3):394-405.
7. Gothe S., Wang Z., Ng L., Kindblom J.M., Barros A.C., Ohlsson C., Vennstrom B., Forrest D. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes & Development 1999, 13(10):1329-1341.
8. Gu Y., Fan W., Yin G. The study of mechanisms of protective effect of Rg1 against arthritis by inhibiting osteoclast differentiation and maturation in CIA mice. Mediators of Inflammation 2014, 2014. 305071.
9. He L., Lee J., Jang J.H., Lee S.H., Nan M.H., Oh B.C., Lee S.G., Kim H.H., Soung N.K., Ahn J.S., Kim B.Y. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-kappaB, NFATc1 and c-Fos. Bone 2012, 50(6):1207-1213.
10. Jang Y.J., Kim M.E., Ko S.Y. n-Butanol extracts of Panax notoginseng suppress LPS-induced MMP-2 expression in periodontal ligament fibroblasts and inhibit osteoclastogenesis by suppressing MAPK in LPS-activated RAW264.7 cells. Archives of Oral Biology 2011, 56(11):1319-1327.
11. Jarvinen T.L., Sievanen H., Kannus P., Jarvinen M. Dual-energy X-ray absorptiometry in predicting mechanical characteristics of rat femur. Bone 1998, 22(5):551-558.
12. Jeong K.J., Kim G.W., Chung S.H. AMP-activated protein kinase: An emerging target for ginseng. Journal of Ginseng Research 2014, 38(2):83-88.
13. Jhun J., Lee J., Byun J.K., Kim E.K., Woo J.W., Lee J.H., Kwok S.K., Ju J.H., Park K.S., Kim H.Y., Park S.H., Cho M.L. Red ginseng extract ameliorates autoimmune arthritis via regulation of STAT3 pathway, Th17/Treg balance, and osteoclastogenesis in mice and human. Mediators of Inflammation 2014, 2014. 351856.
14. Jiang S.D., Shen C., Jiang L.S., Dai L.Y. Differences of bone mass and bone structure in osteopenic rat models caused by spinal cord injury and ovariectomy. Osteoporosis International 2007, 18(6):743-750.
15. Kannus P., Jarvinen T.L., Sievanen H., Kvist M., Rauhaniemi J., Maunu V.M., Hurme T., Jozsa L., Jarvinen M. Effects of immobilization, three forms of remobilization, and subsequent deconditioning on bone mineral content and density in rat femora. Journal of Bone and Mineral Research 1996, 11(9):1339-1346.
16. Kastl S., Sommer T., Klein P., Hohenberger W., Engelke K. Accuracy and precision of bone mineral density and bone mineral content in excised rat humeri using fan beam dual-energy X-ray absorptiometry. Bone 2002, 30(1):243-246.
17. Kim H.R., Cui Y., Hong S.J., Shin S.J., Kim D.S., Kim N.M., So S.H., Lee S.K., Kim E.C., Chae S.W., Chae H.J. Effect of ginseng mixture on osteoporosis in ovariectomized rats. Immunopharmacology and Immunotoxicology 2008, 30(2):333-345.
18. Kurasawa K. Bone quality and biochemical markers. Clinical Calcium 2005, 15(6):959-964.
19. Liu J., Shiono J., Shimizu K., Yu H., Zhang C., Jin F., Kondo R. 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastogenesis inhibitor without any cytotoxicity. Bioorganic & Medicinal Chemistry Letters 2009, 19(12):3320-3323.
20. Mezquita Raya P., Munoz Torres M., Lopez Rodriguez F., Martinez Martin N., Conde Valero A., Ortego Centeno N., Gonzalez Calvin J., Raya Alvarez E., Luna Jd Jde D., Escobar Jimenez F. Prevalence of vitamin D deficiency in populations at risk for osteoporosis: Impact on bone integrity. Medicina Clínica (Barcelona) 2002, 119(3):85-89.
21. Nelson E.R., Wardell S.E., McDonnell D.P. The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis. Bone 2013, 53(1):42-50.
22. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy Osteoporosis prevention, diagnosis, and therapy. JAMA: The Journal of the American Medical Association 2001, 285(6):785-795.
23. Orija I.B., Mehta A. Hormone replacement therapy: Current controversies. Clinical Endocrinology 2003, 59(5):657.
24. Park J.A., Ha S.K., Kang T.H., Oh M.S., Cho M.H., Lee S.Y., Park J.H., Kim S.Y. Protective effect of apigenin on ovariectomy-induced bone loss in rats. Life Sciences 2008, 82(25-26):1217-1223.
25. Polan M.L., Hochberg R.B., Trant A.S., Wuh H.C. Estrogen bioassay of ginseng extract and ArginMax, a nutritional supplement for the enhancement of female sexual function. Journal of Women's Health 2004, 13(4):427-430.
26. Putnam S.E., Scutt A.M., Bicknell K., Priestley C.M., Williamson E.M. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytotherapy Research 2007, 21(2):99-112.
27. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA: The Journal of the American Medical Association 2002, 288(3):321-333. Writing Group for the Women's Health Initiative, I.
28. Shen Y., Li Y.Q., Li S.P., Ma L., Ding L.J., Ji H. Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. Journal of Natural Medicines 2010, 64(3):336-345.
29. Shin H.Y., Jeong H.J., Hyo Jin A., Hong S.H., Um J.Y., Shin T.Y., Kwon S.J., Jee S.Y., Seo B.I., Shin S.S., Yang D.C., Kim H.M. The effect of Panax ginseng on forced immobility time & immune function in mice. Indian Journal of Medical Research 2006, 124(2):199-206.
30. Wang S.W., Kuo H.C., Hsu H.F., Tu Y.K., Cheng T.T., Houng J.Y. Inhibitory activity on RANKL-mediated osteoclastogenesis of Glossogyne tenuifolia extract. Journal of Functional Foods 2014, 6:215-223.
31. Wang W., Zhao Y., Rayburn E.R., Hill D.L., Wang H., Zhang R. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemotherapy and Pharmacology 2007, 59(5):589-601.
32. Withold W. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers. European Journal of Clinical Chemistry and Clinical Biochemistry 1996, 34(10):785-799.
33. Yang L.C., Lu T.J., Lin W.C. The prebiotic arabinogalactan of Anoectochilus formosanus prevents ovariectomy-induced osteoporosis in mice. Journal of Functional Foods 2013, 5:1642-1653.
34. Yin J., Tezuka Y., Subehan, Shi L., Nobukawa M., Nobukawa T., Kadota S. In vivo anti-osteoporotic activity of isotaxiresinol, a lignan from wood of Taxus yunnanensis. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 2006, 13(1-2):37-42.